Back
Day Range
$6.12
$6.50
52-Week Range
$3.50
$23.20
Volume
2,538,353
50D / 200D Avg
$7.86
/
$9.48
Prev Close
$6.21
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.2 | 0.4 |
| P/B | 0.3 | 2.9 |
| ROE % | -88.7 | 3.7 |
| Net Margin % | -266.3 | 3.8 |
| Rev Growth 5Y % | 16.1 | 10.0 |
| D/E | 0.2 | 0.2 |
Key Takeaways
Revenue grew 16.13% annually over 5 years — strong growth
Debt/Equity of 0.22 — conservative balance sheet
Negative free cash flow of -174.98M
Revenue growth is decelerating — 1Y growth trails 5Y average by 11.29%
Capital efficient — spends only 4.01% of revenue on capex
Growth
Revenue Growth (5Y)
16.13%
Revenue (1Y)4.84%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-88.71%
ROIC-93.03%
Net Margin-266.25%
Op. Margin-277.93%
Safety
Debt / Equity
0.22
Current Ratio2.46
Interest Coverage-55.23
Valuation
P/E Ratio
-0.22
P/B Ratio0.31
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.84% | Revenue Growth (3Y) | 15.51% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 16.13% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.13B | Net Income (TTM) | -3.00B |
| ROE | -88.71% | ROA | -103.31% |
| Gross Margin | 29.29% | Operating Margin | -277.93% |
| Net Margin | -266.25% | Free Cash Flow (TTM) | -174.98M |
| ROIC | -93.03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.22 | Current Ratio | 2.46 |
| Interest Coverage | -55.23 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -0.22 | P/B Ratio | 0.31 |
| P/S Ratio | 0.58 | PEG Ratio | 0.00 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 653.05M | Enterprise Value | 799.97M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.13B | 1.07B | 844.72M | 792.12M | 619.67M |
| Net Income | -3.00B | -333.80M | -1.96B | -601.05M | -443.75M |
| EPS (Diluted) | -33.80 | -4.50 | -31.70 | -11.30 | -15.10 |
| Gross Profit | 330.11M | 304.33M | 197.95M | 147.26M | 148.77M |
| Operating Income | -3.13B | -238.10M | -1.84B | -769.46M | -159.63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.90B | 5.91B | 5.92B | 6.87B | 6.03B |
| Total Liabilities | 860.49M | 1.22B | 1.44B | 1.27B | 1.56B |
| Shareholders' Equity | 2.07B | 4.69B | 4.47B | 5.55B | 4.46B |
| Total Debt | 451.09M | 527.75M | 794.89M | 786.36M | 938.66M |
| Cash & Equivalents | 304.17M | 311.13M | 278.33M | 524.29M | 488.47M |
| Current Assets | 944.93M | 923.43M | 1.04B | 1.01B | 883.61M |
| Current Liabilities | 384.63M | 407.64M | 583.21M | 353.39M | 401.24M |